Tak Paul Peter — SEC Form 4 filings
SEC reporting owner CIK 1873905. 11 Form 4 filings on record with FilingPulse; latest filed 2026-09-11.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2024-07-15 to 2026-09-11. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 9 legs across 7 filings — 440,961 shares, $4,210,775 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 7.
- Largest priced transaction: sale of 220,866 shares @ $11.50 ($2,539,893) in Candel Therapeutics, Inc., filed 2026-09-11.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Candel Therapeutics, Inc. (CADL) | Chief Executive Officer, Director | 11 | — | 9 legs · 440,961 sh · $4,210,775 | 7 |
Form 4 filings — Tak Paul Peter
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-09-11 | 4 | Candel Therapeutics, Inc. (CADL) | Option exercise (M): 125,000 @ $1.55 · Sale (S): 220,866 @ $11.50 · Sale (S): 59,379 @ $10.46 · Option exercise (M): 125,000 (derivative) @ $0 | EDGAR |
| 2026-01-28 | 4 | Candel Therapeutics, Inc. (CADL) | Grant/award (A): 629,000 (derivative) @ $0 | EDGAR |
| 2025-06-26 | 4 | Candel Therapeutics, Inc. (CADL) | Grant/award (A): 42,826 @ $4.67 | EDGAR |
| 2025-03-20 | 4 | Candel Therapeutics, Inc. (CADL) | Sale (S): 25,772 @ $8.77 · Sale (S): 400 @ $9.00 | EDGAR |
| 2025-02-14 | 4 | Candel Therapeutics, Inc. (CADL) | Grant/award (A): 525,000 (derivative) @ $0 | EDGAR |
| 2025-01-17 | 4 | Candel Therapeutics, Inc. (CADL) | Sale (S): 21,704 @ $7.22 | EDGAR |
| 2025-01-10 | 4 | Candel Therapeutics, Inc. (CADL) | Sale (S): 21,172 @ $8.22 | EDGAR |
| 2024-12-03 | 4 | Candel Therapeutics, Inc. (CADL) | Sale (S): 48,847 @ $4.56 | EDGAR |
| 2024-11-21 | 4 | Candel Therapeutics, Inc. (CADL) | Option exercise (M): 12,900 @ $1.55 · Option exercise (M): 12,900 (derivative) @ $0 | EDGAR |
| 2024-07-19 | 4 | Candel Therapeutics, Inc. (CADL) | Sale (S): 22,528 @ $6.47 | EDGAR |
| 2024-07-15 | 4 | Candel Therapeutics, Inc. (CADL) | Sale (S): 20,293 @ $5.97 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2024-01-11 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1873905 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →